1      0

CS-01 - Moving Beyond HbA1c: New Standards for Assessing Glycemic Control—The Evidence and Role of Sensor-Based Continuous Glucose Monitoring (CGM) for Improving Patient Care and Satisfaction in Persons with Type 2 Diabetes

‐ Jun 23, 2023 8:30pm

(6:30 p.m.-7:00 p.m.—Dinner/7:00 p.m.-8:30 p.m.—Program)

This program will focus on emerging digital, real time-, and patch-based technologies for continuous monitoring of glucose levels, to improve drug interventions for diabetes, minimize risks of hypoglycemia, maximize time in target range for blood glucose, and to optimize treatment interventions and drug titration. The program will discuss and communicate the evidentiary basis for sensor-based glucose monitoring technologies, as well as strategies for how diabetes-focused specialists should communicate, collaborate, and implement CGM-based technologies into their overall diabetes care plans.

You must be logged in and own this session in order to post comments.